Quality of Life in Japanese Patients with Dysmenorrhea Treated with Ethinylestradiol 20 μg/Drospirenone 3 mg in a Real-World Setting: An Observational Study

by Momoeda M, Akiyama S, Tanaka K, Suzukamo Y
Published 2020-05-01

Burden of Menstrual Pain Measured by Heatmap Visualization of Daily Patient-Reported Data in Japanese Patients Treated with Ethinylestradiol/Drospirenone: A Randomized Controlled S...

by Momoeda M, Akiyama S, Yamamoto S, Kondo M, Fukai T
Published 2020-03-01

Efficacy and safety of a flexible extended regimen of ethinylestradiol/drospirenone for the treatment of dysmenorrhea: a multicenter, randomized, open-label, active-controlled stud...

by Momoeda M, Kondo M, Elliesen J, Yasuda M, Yamamoto S, Harada T
Published 2017-05-01

Does the presence of coexisting diseases modulate the effectiveness of a low-dose estrogen/progestin, ethinylestradiol/drospirenone combination tablet in dysmenorrhea? Reanalysis o...

by Momoeda M, Hayakawa M, Shimazaki Y, Mizunuma H, Taketani Y
Published 2014-12-01

Burden of menstrual symptoms in Japanese women – an analysis of medical care-seeking behavior from a survey-based study

by Tanaka E, Momoeda M, Osuga Y, Rossi B, Nomoto K, Hayakawa M, Kokubo K, Wang ECY
Published 2013-12-01